U.S. Food and Drug Administration
Approved Methods of Birth Control
Sean Murphy*
Introduction
The U.S. Food and Drug Administration (FDA) approves drugs
and devices that are used for birth control, offering a list of
different kinds of birth control in a
Birth Control Guide. It refers globally to all of
these birth control methods as "contraception" or
"contraceptives."
This terminology is highly contentious because it includes
surgical sterilization, and because it ignores differences in
the mechanisms of action of some products that are considered
morally significant by many people. It has now become
legally significant because of a Department of Health and Human
Services
regulation that will force all insurance plans to provide
coverage for anything the Food and Drug Administration has
approved as a 'contraceptive.'
The regulation has launched a firestorm of protest across the
United States. It is generating lawsuits against the U.S.
federal government, as well as legislation in some states to
prevent the regulation from taking effect.
The following table classifies birth control methods listed
in the FDA Birth Control
Guide as
"contraceptive", "embryocide" or "abortifacient" according to
their reported mechanism of action. Some drugs or devices
may have more than one mechanism of action.
The classification here uses the following definitions:
- Contraceptive: a drug or device that
prevents or may prevent the union of sperm and egg, thus preventing the
formation of an embryo.
- Embryocide: a drug or device that
causes or may cause the death of a human embryo before
implantation in the uterus.
- Abortifacient: a drug or device that probably has or is designed or intended to cause the death of a human embryo or foetus after
implantation in the uterus.
For more detailed explanation of this terminology, see
Clearing Rhetorical Minefields.
Kinds of Birth Control
Notes
1. Hysteroscopic Tubal Sterilization is
a procedure that involves the implantation of a tubal occlusion
device (TOD) in the fallopian tubes. This elicits a benign
tissue response, causing tissue to grow into the device and
block the tube.